Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $22,539 | 3 | 50.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,980 | 11 | 29.3% |
| Consulting Fee | $7,260 | 1 | 16.4% |
| Food and Beverage | $1,076 | 10 | 2.4% |
| Travel and Lodging | $459.59 | 2 | 1.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BRACCO DIAGNOSTICS INC. | $23,103 | 6 | $0 (2018) |
| GE HealthCare | $13,131 | 12 | $0 (2022) |
| Vertex Pharmaceuticals Incorporated | $7,260 | 1 | $0 (2021) |
| Siemens Medical Solutions USA, Inc. | $526.69 | 4 | $0 (2023) |
| Medtronic, Inc. | $178.67 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $114.28 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $356.82 | 2 | Medtronic, Inc. ($178.67) |
| 2022 | $440.00 | 1 | GE HealthCare ($440.00) |
| 2021 | $9,020 | 6 | Vertex Pharmaceuticals Incorporated ($7,260) |
| 2020 | $10,915 | 6 | GE HEALTHCARE ($10,780) |
| 2019 | $270.25 | 2 | GE HEALTHCARE ($151.27) |
| 2018 | $23,184 | 7 | BRACCO DIAGNOSTICS INC. ($23,103) |
| 2017 | $128.30 | 3 | Siemens Medical Solutions USA, Inc. ($94.48) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2023 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $178.67 | General |
| Category: Aortic Stent Grafts | ||||||
| 01/03/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $178.15 | General |
| 01/26/2022 | GE HealthCare | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| 05/19/2021 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: CORE IMAGING | ||||||
| 05/19/2021 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: CORE IMAGING | ||||||
| 05/19/2021 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $220.00 | General |
| Category: CORE IMAGING | ||||||
| 05/19/2021 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $220.00 | General |
| Category: CORE IMAGING | ||||||
| 03/01/2021 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: CORE IMAGING | ||||||
| 02/03/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $7,260.00 | General |
| 06/16/2020 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: CORE IMAGING | ||||||
| 06/02/2020 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,840.00 | General |
| Category: CORE IMAGING | ||||||
| 06/02/2020 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,290.00 | General |
| Category: CORE IMAGING | ||||||
| 06/02/2020 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $770.00 | General |
| Category: CORE IMAGING | ||||||
| 06/02/2020 | GE HEALTHCARE | OPTISON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: CORE IMAGING | ||||||
| 02/13/2020 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $135.08 | General |
| 06/23/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $151.27 | General |
| 02/08/2019 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $118.98 | General |
| 10/05/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $80.46 | General |
| 08/07/2018 | BRACCO DIAGNOSTICS INC. | LUMASON (Drug) | — | Cash or cash equivalent | $2,500.00 | Research |
| Study: A Multicenter Clinical Evaluation of Safety and Efficacy of SonoVue as a Contrast Agent in Pediatric Echocardiography • Category: CONTRAST MEDIA | ||||||
| 08/07/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Travel and Lodging | Cash or cash equivalent | $75.72 | General |
| Category: CONTRAST MEDIA | ||||||
| 05/01/2018 | BRACCO DIAGNOSTICS INC. | LUMASON (Drug) | — | Cash or cash equivalent | $20,000.00 | Research |
| Study: A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease • Category: CONTRAST MEDIA | ||||||
| 03/27/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Travel and Lodging | Cash or cash equivalent | $383.87 | General |
| Category: CONTRAST MEDIA | ||||||
| 03/27/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Food and Beverage | Cash or cash equivalent | $104.76 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/06/2018 | BRACCO DIAGNOSTICS INC. | LUMASON (Drug) | — | Cash or cash equivalent | $38.99 | Research |
| Study: A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease • Category: CONTRAST MEDIA | ||||||
| 08/31/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $16.59 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease | BRACCO DIAGNOSTICS INC. | $20,039 | 2 |
| A Multicenter Clinical Evaluation of Safety and Efficacy of SonoVue as a Contrast Agent in Pediatric Echocardiography | BRACCO DIAGNOSTICS INC. | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 341 | 403 | $88,795 | $20,740 |
| 2022 | 12 | 358 | 398 | $71,615 | $16,929 |
| 2021 | 12 | 951 | 966 | $547,887 | $32,513 |
| 2020 | 13 | 1,247 | 1,277 | $825,486 | $47,458 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 49 | 49 | $22,295 | $4,535 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 34 | $10,880 | $3,115 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 50 | $10,750 | $3,045 | 28.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 50 | 50 | $12,000 | $2,404 | 20.0% |
| 75561 | Mri scan of heart before and after contrast | Office | 2023 | 19 | 19 | $8,645 | $1,795 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 17 | $5,255 | $1,700 | 32.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $5,180 | $1,138 | 22.0% |
| 71555 | Mri scan of blood vessels of chest | Facility | 2023 | 15 | 15 | $4,725 | $969.53 | 20.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $3,300 | $927.90 | 28.1% |
| 75565 | Mri scan of blood flow of heart | Facility | 2023 | 36 | 36 | $1,800 | $318.50 | 17.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 14 | $1,190 | $266.00 | 22.4% |
| 75565 | Mri scan of blood flow of heart | Office | 2023 | 19 | 19 | $950.00 | $172.90 | 18.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 27 | 27 | $675.00 | $147.96 | 21.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 14 | 14 | $700.00 | $135.94 | 19.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 30 | 30 | $450.00 | $69.70 | 15.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 77 | 77 | $18,480 | $4,201 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 55 | $9,900 | $3,023 | 30.5% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2022 | 32 | 32 | $14,240 | $2,925 | 20.5% |
| 75561 | Mri scan of heart before and after contrast | Office | 2022 | 24 | 24 | $10,680 | $2,341 | 21.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,740 | $1,154 | 30.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 13 | 14 | $5,180 | $1,145 | 22.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 30 | 31 | $2,635 | $588.76 | 22.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $2,035 | $580.76 | 28.5% |
| 75565 | Mri scan of blood flow of heart | Facility | 2022 | 27 | 27 | $1,215 | $254.88 | 21.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 33 | 33 | $825.00 | $187.53 | 22.7% |
About Dr. Yuchi Han, MD
Dr. Yuchi Han, MD is a Cardiovascular Disease healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164498291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yuchi Han, MD has received a total of $44,314 in payments from pharmaceutical and medical device companies, with $356.82 received in 2023. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "" ($22,539).
As a Medicare-enrolled provider, Han has provided services to 2,897 Medicare beneficiaries, totaling 3,044 services with total Medicare billing of $117,640. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Columbus, OH
- Active Since 02/28/2006
- Last Updated 10/10/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164498291
Products in Payments
- LUMASON (Drug) $22,539
- OPTISON (Drug) $12,540
- SonoVue (Drug) $564.35
- ENDURANT IIS (Device) $178.67
- Non-Product Specific (Device) $94.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbus
Gary Ansel, Md, MD
Cardiovascular Disease — Payments: $4.6M
Hunter Champion, M.d, M.D
Cardiovascular Disease — Payments: $1.7M
Steven Yakubov, Md, MD
Cardiovascular Disease — Payments: $1.2M
Mitchell Silver, Do, DO
Cardiovascular Disease — Payments: $781,405
Rami Kahwash, M.d, M.D
Cardiovascular Disease — Payments: $425,557
John Phillips, M.d, M.D
Cardiovascular Disease — Payments: $395,324